PAR 3.92% 24.5¢ paradigm biopharmaceuticals limited..

Yes 1.9 B US valuation and awaiting two x phase 1 results and...

  1. 3,010 Posts.
    lightbulb Created with Sketch. 1837
    Yes 1.9 B US valuation and awaiting two x phase 1 results and initiating a phase 2. Up 64% in a day. We are significantly undervalued in global terms for our prospects.

    IMO opinion only, not advice and do your own research.
    Last edited by Eire2011: 13/09/22
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
24.5¢
Change
-0.010(3.92%)
Mkt cap ! $85.70M
Open High Low Value Volume
24.5¢ 25.0¢ 24.0¢ $59.66K 241.2K

Buyers (Bids)

No. Vol. Price($)
4 78837 24.5¢
 

Sellers (Offers)

Price($) Vol. No.
25.0¢ 36290 1
View Market Depth
Last trade - 16.10pm 30/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.